Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for creating T cell-based therapies
Rosenberg, S. A. & Restifo, N. P. Adoptive cell switch as personalised immunotherapy for human most cancers. Science 348, 62–68 (2015). Article PubMed PubMed Central Google Scholar Fesnak, A. D., June, C. H. & Levine, B. L. Engineered T cells: the promise and challenges of most cancers immunotherapy. Nat. Rev. Most cancers 16, 566–581 (2016)….